RxDoctor Payments Data

Jessica Cain, PA

Physician Assistant · Raleigh, NCNPI 1235178302

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $56,730 of the $77,178 with a category attached, or 73.5%. 54 manufacturers reported payments, led by AbbVie at 26.4% of the total. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,178in general payments, 2019–2025

Across 799 payments — averaging $96.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$20K
  • MDD US Operations, LLC$16K
  • Amgen$14K
  • Axsome Therapeutics, Inc.$5K
  • Biohaven Pharmaceutical Holding Company Ltd.$5K
  • Argenx US, Inc.$4K
  • plus $13K from 48 others

What the payments were for

  • Consulting fees$4,0255%
  • Speaking & faculty fees$56,73074%
  • Travel & lodging$4,0735%
  • Food & beverage$12,01916%
  • Education$3300%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,178 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,829
Medicare patients
225
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PanzygaImmun Glob G(Igg)-Ifas/Glycine36$282,345
NuplazidPimavanserin Tartrate23$104,592
Aimovig AutoinjectorErenumab-Aooe36$37,335
QuliptaAtogepant11$19,002
Nurtec OdtRimegepant Sulfate16$16,445
Gabapentin ErGabapentin13$9,422
AdlarityDonepezil Hcl13$5,802
Levetiracetam ErLevetiracetam39$4,446
Levetiracetam109$3,624
Memantine Hcl136$3,226
Sumatriptan Succinate27$3,171
Gabapentin149$2,971
Carbidopa-LevodopaCarbidopa/Levodopa79$2,452
Lacosamide15$2,410
Rivastigmine15$2,029

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPanzyga, Nurtec Odt$264$298,79152 claims
Acadia Pharmaceuticals IncNuplazid$342$104,59223 claims
AbbVieQulipta$20,341$19,00211 claims
Corium, LLCAdlarity$15$5,80213 claims
Upsher-smith Laboratories LLCTopiramate$183$48048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →